Page last updated: 2024-08-16

trientine and interleukin-8

trientine has been researched along with interleukin-8 in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kagawa, K; Katagishi, T; Kimura, H; Mitsumoto, Y; Moriguchi, M; Nakajima, T; Okanoue, T; Takashima, H; Watanabe, T	1
Fukui, H; Ikenaka, Y; Kitade, M; Kuriyama, S; Namisaki, T; Noguchi, R; Yamazaki, M; Yanase, K; Yoshii, J; Yoshiji, H	1

Other Studies

2 other study(ies) available for trientine and interleukin-8

Article	Year
The copper chelator trientine has an antiangiogenic effect against hepatocellular carcinoma, possibly through inhibition of interleukin-8 production. International journal of cancer, 2002, Dec-10, Volume: 102, Issue:5 Topics: Angiogenesis Inhibitors; Animals; Apoptosis; Carcinoma, Hepatocellular; Cell Division; Chelating Agents; Copper; Humans; Interleukin-8; Liver Neoplasms; Mice; Neoplasm Transplantation; RNA, Messenger; Transplantation, Heterologous; Trientine; Tumor Cells, Cultured	2002
Combination of copper-chelating agent, trientine, and methotrexate attenuates colorectal carcinoma development and angiogenesis in mice. Oncology reports, 2005, Volume: 14, Issue:1 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Blood Vessels; Cell Line; Cell Line, Tumor; Cell Proliferation; Chelating Agents; Colorectal Neoplasms; Humans; Interleukin-8; Methotrexate; Mice; Mice, Inbred BALB C; Mice, Nude; Neovascularization, Pathologic; Platelet Endothelial Cell Adhesion Molecule-1; RNA, Neoplasm; Treatment Outcome; Trientine; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays	2005

Article

Year

The copper chelator trientine has an antiangiogenic effect against hepatocellular carcinoma, possibly through inhibition of interleukin-8 production.

International journal of cancer, 2002, Dec-10, Volume: 102, Issue:5

Topics: Angiogenesis Inhibitors; Animals; Apoptosis; Carcinoma, Hepatocellular; Cell Division; Chelating Agents; Copper; Humans; Interleukin-8; Liver Neoplasms; Mice; Neoplasm Transplantation; RNA, Messenger; Transplantation, Heterologous; Trientine; Tumor Cells, Cultured

2002

Combination of copper-chelating agent, trientine, and methotrexate attenuates colorectal carcinoma development and angiogenesis in mice.

Oncology reports, 2005, Volume: 14, Issue:1

Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Blood Vessels; Cell Line; Cell Line, Tumor; Cell Proliferation; Chelating Agents; Colorectal Neoplasms; Humans; Interleukin-8; Methotrexate; Mice; Mice, Inbred BALB C; Mice, Nude; Neovascularization, Pathologic; Platelet Endothelial Cell Adhesion Molecule-1; RNA, Neoplasm; Treatment Outcome; Trientine; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays

2005